A UK trial brings personalised treatment to newly diagnosed myeloma patients
Researchers are recruiting newly diagnosed myeloma patients for a UK study, RADAR, to investigate whether personalised treatments could optimise patient care, reduce the risk of early relapse, and increase life expectancy.